Global Prevalence and Major Risk Factors of Diabetic Retinopathy
Open accessThe DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To examine the global prevalence and major risk factors for diabetic retinopathy (DR) and vision-threatening diabetic retinopathy (VTDR) among people with diabetes. RESEARCH DESIGN AND METHODS: A pooled analysis using individual participant data from population-based studies around the world was performed. A systematic literature review was conducted to identify all population-based studies in general populations or individuals with diabetes who had ascertained DR from retinal photographs. Studies provided data for DR end points, including any DR, proliferative DR, diabetic macular edema, and VTDR, and also major systemic risk factors. Pooled prevalence estimates were directly age-standardized to the 2010 World Diabetes Population aged 20–79 years. RESULTS: A total of 35 studies (1980–2008) provided data from 22,896 individuals with diabetes. The overall prevalence was 34.6% (95% CI 34.5–34.8) for any DR, 6.96% (6.87–7.04) for proliferative DR, 6.81% (6.74–6.89) for diabetic macular edema, and 10.2% (10.1–10.3) for VTDR. All DR prevalence end points increased with diabetes duration, hemoglobin A1c, and blood pressure levels and were higher in people with type 1 compared with type 2 diabetes. CONCLUSIONS: There are approximately 93 million people with DR, 17 million with proliferative DR, 21 million with diabetic macular edema, and 28 million with VTDR worldwide. Longer diabetes duration and poorer glycemic and blood pressure control are strongly associated with DR. These data highlight the substantial worldwide public health burden of DR and the importance of modifiable risk factors in its occurrence. This study is limited by data pooled from studies at different time points, with different methodologies and population characteristics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The prognosis for retaining vision has improved dramatically over the past 40 years owing to improved metabolic and BP control.78,432,488–490”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [488]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Globally, the overall prevalence of referable DR has been estimated to be around 10%, but this varies across geographic regions, ethnicities, and study methodologies33.”
From Economic evaluation for medical artificial intelligence: accuracy vs. cost-effectiveness in a diabetic retinopathy screening case (2024) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Patients diagnosed with kidney disease, hypertension, and covered under Medicaid insurance are at higher risk for poor visual outcomes13–24.”
From Autonomous AI-assisted diabetic retinopathy screening at primary care is associated with increased presentation to eye care by at risk patients (2026) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Diabetic retinopathy (DR) is the leading cause of blindness among working-aged adults and early detection is critical for timely management to prevent vision loss1,2.”
From Referral uptake after diabetic retinopathy screening with artificial intelligence-assisted care pathways: a systematic review and meta-analysis (2026) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Artificial intelligence (AI) is an accurate screening tool for diabetic retinopathy (DR), the leading cause of blindness among working-aged adults.”
From Referral uptake after diabetic retinopathy screening with artificial intelligence-assisted care pathways: a systematic review and meta-analysis (2026) · cites this paper as [2]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Global estimates of the prevalence of diabetes for 2010 and 2030
Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.007 · Cited by 7,216
Self-citationColhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., W Neil, H. A., Livingstone, S. J., Thomason, M. J., Mackness, M. I., Charlton-Menys, V., & Fuller, J. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16895-5 · Cited by 3,755 · cited 1×
“Statins, however, did not affect DR severity in the few studies in which this was evaluated, although not as a primary outcome (35,36).”
Prevalence of Diabetes among Men and Women in China
Yang, W., Lu, J., Weng, J., Jia, W., Ji, L., Xiao, J., Shan, Z., Liu, J., Tian, H., Ji, Q., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908292 · Cited by 3,031
Klein, R. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040030398010 · Cited by 1,885 · cited 1×
“We showed that the prevalence of DR is substantially higher in type 1 than in type 2 diabetes (11,37), an outcome independent of diabetes duration.”
Self-citationKlein, R. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040030405011 · Cited by 1,477 · cited 1×
“If data on age at diagnosis of diabetes were available in these studies, participants were classified as type 1 if they were diagnosed before age 30 years and as type 2 if they were diagnosed with diabetes after age 30 years, as previously used in one study (7).”
Self-citationKlein, R., Klein, B. E. K., Moss, S. E., & Linton, K. L. P. (1992) · Ophthalmology · doi:10.1016/s0161-6420(92)32011-1 · Cited by 1,340
Self-citation
Cited by
Items 701–800 of 1,029
Is there any correlation between vitamin D insufficiency and diabetic retinopathy?
Bonakdaran, S., & Shoeibi, N. (2015) · Europe PMC (PubMed Central) · doi:10.3980/j.issn.2222-3959.2015.02.20 · Cited by 51
Lai, T. Y. Y., & Fong, A. H. C. (2013) · Clinical Interventions in Aging · doi:10.2147/cia.s36811 · Cited by 60
“Diabetic macula edema Diabetic macular edema (DME) is a major complication of diabetic retinopathy (DR) and is the most frequent cause for preventable blindness in working adults in many countries.(19) A large meta-analysis has estimated the overall prevalence of any DR to be 34.”
Application of different imaging modalities for diagnosis of Diabetic Macular Edema: A review
Mookiah, M. R. K., Acharya, U. R., Fujita, H., Tan, J. H., Chua, C. K., Bhandary, S. V., Laude, A., & Tong, L. H. T. (2015) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2015.09.012 · Cited by 51
Byun, S.-H., Ma, S. H., Jun, J. K., Jung, K., & Park, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062991 · Cited by 52
“6% worldwide [7].”
De, S., Saxena, S., Kaur, A., Mahdi, A. A., Misra, A., Singh, M., Meyer, C. H., & Akduman, L. (2020) · Eye · doi:10.1038/s41433-020-1100-0 · Cited by 51
“Among them, 21 million have treatable form of diabetic macula oedema (DMO) [1].”
BackgroundMontesano, G., Ometto, G., Higgins, B. E., Das, R., Graham, K. W., Chakravarthy, U., McGuiness, B., Young, I. S., Kee, F., Wright, D. M., et al. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.3.35 · Cited by 53
“1–3 The role of vascular damage and new vessel proliferation is widely recognized and is ultimately responsible for the loss of sight.”
Adults visual impairment and blindness – An overview of prevalence and causes in Saudi Arabia
Alghamdi, A. (2019) · Saudi Journal of Ophthalmology · doi:10.1016/j.sjopt.2019.10.001 · Cited by 54
Papadopoulos, A., Topouzis, F., & Delopoulos, A. N. (2021) · Scientific Reports · doi:10.1038/s41598-021-93632-8 · Cited by 54
Wakasugi, S., Mita, T., Katakami, N., Okada, Y., Yoshii, H., Osonoi, T., Nishida, K., Shiraiwa, T., Torimoto, K., Kurozumi, A., et al. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001923 · Cited by 45
The upcoming role of Artificial Intelligence (AI) for retinal and glaucomatous diseases
Desideri, L. F., Rutigliani, C., Corazza, P., Nastasi, A., Roda, M., Nicolò, M., Traverso, C. E., & Vagge, A. (2022) · Journal of Optometry · doi:10.1016/j.optom.2022.08.001 · Cited by 54
“In this regard, many studies have proven that DL systems and algorithms can accurately identify DR. 15 Abr (cid:1) amoff et al. reported a sensitivity of 96.8% and a speci fi city of 87% and an area under the receiver operating characteristic curve (AUC) of 0.980, for detecting referable DR on the publicly available Me…”
BackgroundInfluentialWang, R., McClard, C. K., Laswell, S. M., Mahmoudzadeh, R., Salabati, M., Ammar, M. J., Vannavong, J., Aziz, A. A., Ewald, A., Calvanese, A. V., et al. (2022) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2022-001188 · Cited by 51
Microvascular and Endothelial Dysfunction in Prediabetes
Lamprou, S., Koletsos, N., Mintziori, G., Anyfanti, P., Trakatelli, C., Kotsis, V., Gkaliagkousi, Ε., & Triantafyllou, Α. (2023) · Life · doi:10.3390/life13030644 · Cited by 59
“, concerning the global prevalence of DR, it was demonstrated that 35% of patients with DM will develop some type of retinopathy (proliferative in 7% of the cases) [45].”
BackgroundResilience to diabetic retinopathy
Serikbaeva, A., Li, Y., Ma, S., Yi, D., & Kazlauskas, A. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101271 · Cited by 51
Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy
LeBlanc, M. E., Wang, W., Chen, X., Caberoy, N. B., Guo, F., Shen, C., Ji, Y., Tian, H., Wang, H., Chen, R., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20161802 · Cited by 51
“Anti-Scg3 therapy of retinal angiogenesis In contrast to diabetic patients who may develop PDR 10–20 yr after the disease onset (Yau et al., 2012), diabetic rodents do not progress toward PDR, probably because of their relatively short lifespan.”
Adherence to diabetic eye examination guidelines in Australia: the National Eye Health Survey
Foreman, J., Keel, S., Xie, J., Van Wijngaarden, P., Taylor, H. R., & Dirani, M. (2017) · Medical Journal of Australia · doi:10.5694/mja16.00989 · Cited by 50
Self-citationRetinal blood vessel segmentation by support vector machine classification
Tuba, E., Mrkela, L., & Tuba, M. (2017) · International Conference Radioelektronika · doi:10.1109/radioelek.2017.7936649 · Cited by 50
Elwali, E. S., Almobarak, A. O., Hassan, M. A., Mahmooud, A. A., Awadalla, H., & Ahmed, M. H. (2017) · International Journal of Ophthalmology · doi:10.18240/ijo.2017.06.18 · Cited by 59
Chatziralli, I., THEODOSSIADIS, P. G., Parikakis, E., Dimitriou, E., Xirou, T., THEODOSSIADIS, G. P., & Kabanarou, S. A. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0332-x · Cited by 50
Associations between sleep duration, sleep quality and diabetic retinopathy
Tan, N. Y. Q., Chew, M., Tham, Y. C., Nguyen, Q. D., Yasuda, M., Cheng, C., Wong, T. Y., & Sabanayagam, C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196399 · Cited by 56
Self-citationLi, Y., Busoy, J. M. F., Zaman, B. A. A., Tan, Q. S. W., Tan, G. S. W., Barathi, V. A., Cheung, N., Wei, J., Hunziker, W., Hong, W., et al. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.05.027 · Cited by 52
Self-citationTeliti, M., Cogni, G., Sacchi, L., Dagliati, A., Marini, S., Tibollo, V., Cata, P. D., Bellazzi, R., & Chiovato, L. (2018) · Diabetes and Vascular Disease Research · doi:10.1177/1479164118780808 · Cited by 54
Fan, W., Nittala, M. G., Velaga, S. B., Hirano, T., Wykoff, C. C., Ip, M. S., Lampen, S. I. R., Hemert, J. I. V., Fleming, A. D., Verhoek, M., et al. (2019) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2019.04.023 · Cited by 50
Vaz-Pereira, S., Morais-Sarmento, T., & Marques, R. (2020) · International Journal of Retina and Vitreous · doi:10.1186/s40942-020-00230-3 · Cited by 54
Chatziralli, I., Touhami, S., Cicinelli, M. V., Agapitou, C., Dimitriou, E., THEODOSSIADIS, G. P., & THEODOSSIADIS, P. G. (2021) · Eye · doi:10.1038/s41433-021-01750-4 · Cited by 51
Jenkins, A. J., Grant, M. B., & Busik, J. V. (2022) · Diabetologia · doi:10.1007/s00125-022-05655-z · Cited by 51
“Ocular delivery may increase Table 1 (continued) Study Diabetes type Type of DR n Blood lipids evaluated Results Meta-analyses Yau et al [27] (META-EYE) T1D+T2D DR, PDR, STDR, DMO, CSMO 22,896 TC Higher TC associated with higher prevalence of DMO Zhou et al [28] T1D+T2D DR 4366 TC, TG, LDL-C, HDL-C TC, TG, HDL-C: no d…”
BackgroundLv, Q., Li, Z., Sui, A., Yang, X., Han, Y., & Yao, R. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.977187 · Cited by 59
“Dyslipidemia, chronic inflammation, and high blood pressure are recognized as the major risk factors for developing DR (Mitchell et al., 2018).”
BackgroundZhou, J., Song, S., Zhang, Y., Jin, K., & Ye, J. (2022) · Ophthalmology and Therapy · doi:10.1007/s40123-022-00576-x · Cited by 51
“Diabetes macular edema (DME) is the most common sight-threatening complication of diabetic retinopathy (DR) [1], estimated to affect nearly 5–10% of patients with diabetes mellitus (DM) [2, 3].”
BackgroundNguyen, H., Lee, S., & Li, Y. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112476 · Cited by 50
Gurung, R. L., FitzGerald, L. M., Liu, E., McComish, B. J., Kaidonis, G., Ridge, B., Hewitt, A. W., Vote, B. J. T., Verma, N., Craig, J. E., et al. (2023) · International Journal of Retina and Vitreous · doi:10.1186/s40942-023-00453-0 · Cited by 53
“Introduction Diabetic macular edema (DME) is the leading cause of vision loss in the working-age population [1, 2].”
BackgroundNovel artificial intelligence algorithms for diabetic retinopathy and diabetic macular edema
Yao, J., Lim, J., Lim, G. Y. S., Ong, J. C. L., Ke, Y., Tan, T. F., Tan, T., Vujosevic, S., & Ting, D. S. W. (2024) · Eye and Vision · doi:10.1186/s40662-024-00389-y · Cited by 57
Liu, Z., Liu, L., Chen, X., He, W., & Yu, X. (2014) · Gene · doi:10.1016/j.gene.2014.05.052 · Cited by 49
Park, Y.-H., Shin, J. A., Han, J.-H., Park, Y., & Yim, H. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125338 · Cited by 49
“It is well known that the risk factors of DR include the duration of DM, blood pressure, poor glycemic control, and obesity [5,6].”
BackgroundResultInfluentialJeon, S., & Lee, W. K. (2014) · Retina · doi:10.1097/iae.0000000000000109 · Cited by 53
Chakravarthy, H., Beli, E., Navitskaya, S., O’Reilly, S., Wang, Q., Kady, N., Huang, C., Grant, M. B., & Busik, J. V. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146829 · Cited by 52
“DR is an important long-term complication of diabetes, affecting around 93 million people and is a leading cause of blindness among working adults worldwide [1].”
BackgroundCost of diabetic retinopathy and macular oedema in a population, an eight year follow up
Romero-Aroca, P., de la Riva-Fernandez, S., Valls-Mateu, A., Sagarra-Alamo, R., Moreno-Ribas, A., Soler, N., & Puig, D. (2016) · BMC Ophthalmology · doi:10.1186/s12886-016-0318-x · Cited by 46
Fundus autofluorescence lifetimes are increased in non‐proliferative diabetic retinopathy
Schmidt, J., Peters, S., Sauer, L., Schweitzer, D., Klemm, M., Augsten, R., Muller, N., & Hammer, M. (2016) · Acta Ophthalmologica · doi:10.1111/aos.13174 · Cited by 49
“Published by John Wiley & Sons Ltd doi: 10.1111/aos.13174 Introduction Diabetic retinopathy (DR) is one of the most frequent long-term complication of diabetes mellitus and a major cause of blindness in industrialized nations (Yau et al. 2012; Cai & McGinnis 2016).”
InfluentialHagenau, F., Vogt, D., Ziada, J., Guenther, S. R., Haritoglou, C., Wolf, A., Priglinger, S. G., & Schumann, R. G. (2018) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2018.12.004 · Cited by 49
Yang, J., Chen, C., McLaughlin, T., Wang, Y., Le, Y.-Z., Wang, J. J., & Zhang, S. X. (2019) · Diabetologia · doi:10.1007/s00125-018-4776-y · Cited by 51
“X-box binding protein 1 Abbreviations ATF4 Activating transcription factor 4 ATF6 Activating transcription factor 6 eIF2α Eukaryotic translation initiation factor 2α ER Endoplasmic reticulum ERAD ER-associated degradation ERG Electroretinography GRP78 78 kDa glucose-regulated protein HIF1-α Hypoxia-inducible transcrip…”
BackgroundSelf-citationSex-Gender Differences in Diabetic Retinopathy
Cherchi, S., Gigante, A., Spanu, M. A., Contini, P., Meloni, G., Fois, M. A., Pistis, D., Pilosu, R., Lai, A., Ruiu, S., et al. (2020) · Diabetology · doi:10.3390/diabetology1010001 · Cited by 58
Riordan, F., Racine, E., Phillip, E. T., Bradley, C., Lorencatto, F., Murphy, M. E., Murphy, A., Browne, J. P., Smith, S. M., Kearney, P. M., et al. (2020) · Implementation Science · doi:10.1186/s13012-020-00982-4 · Cited by 52
“Worldwide, it is estimated that approximately 28 million individuals have vision-threatening retinopathy [4].”
BackgroundA critical review: Psychophysical assessments of diabetic retinopathy
Chen, X. D., & Gardner, T. W. (2020) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2020.08.003 · Cited by 50
Gao, Z., Jin, K., Yan, Y., Liu, X., Shi, Y., Ge, Y., Pan, X., Lu, Y., Wu, J., Wang, Y., et al. (2022) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-021-05503-7 · Cited by 53
Liang, G., Qin, Z., Luo, Y., Yin, J., Shi, Z., Wei, R., & Ma, W. (2022) · Gene Therapy · doi:10.1038/s41434-021-00310-5 · Cited by 51
Decrease in Choroidal Vascularity Index of Haller’s layer in diabetic eyes precedes retinopathy
Foo, V. H. X., Gupta, P., Nguyen, Q. D., Chong, C. C. Y., Agrawal, R. V., Cheng, C., & Yanagi, Y. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001295 · Cited by 48
Akıl, H., Burgess, J., Nevitt, S. J., Harding, S. P., Alam, U., & Burgess, P. I. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01190-z · Cited by 51
The role of inflammation and neurodegeneration in diabetic macular edema
Starace, V., Battista, M., Brambati, M., Cavalleri, M., Bertuzzi, F., Amato, A., Lattanzio, R., Bandello, F. M., & Cicinelli, M. V. (2021) · Therapeutic Advances in Ophthalmology · doi:10.1177/25158414211055963 · Cited by 61
“These results suggest that simultaneous blocking of Ang-2 and VEGF in DME may lead to better visual gains and longer duration of treatment’s effect than anti-VEGF alone. journals.sagepub.com/home/oed 9”
BackgroundInfluentialA Regression-Based Approach to Diabetic Retinopathy Diagnosis Using Efficientnet
Vijayan, M., & Venkatakrishnan, S. (2023) · Diagnostics · doi:10.3390/diagnostics13040774 · Cited by 56
“DR is the leading cause of blindness among adults worldwide [1].”
BackgroundMeng, Z., Chen, Y., Li, H., Zhang, Y., Yao, X., Meng, Y., Shi, W., Liang, Y., Hu, Y., Liu, D., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05141-7 · Cited by 48
“A comprehensive meta-analysis revealed a 6.8% global prevalence of DME in individuals aged 20–79 years with diabetes [3].”
BackgroundInfluentialBavinger, J. C., Dunbar, G. E., Stem, M. S., Blachley, T. S., Kwark, L., Farsiu, S., Jackson, G. R., & Gardner, T. W. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-17281 · Cited by 50
“Of these, 21 million have macular edema and 17 million have proliferative DR (PDR).(1) These late-stage forms of DR are”
BackgroundMysona, B. A., Matragoon, S., Stephens, M., Mohamed, I., Farooq, A., Bartasis, M. L., Fouda, A. Y., Shanab, A. Y., Espinosa‐Heidmann, D. G., & El‐Remessy, A. B. (2015) · BioMed Research International · doi:10.1155/2015/571456 · Cited by 50
“Diabetic retinopathy (DR), a leading cause of blindness in working age adults, is estimated to affect 101 million people worldwide [1].”
BackgroundYang, J. Y., Kim, N. K., Lee, Y. J., Noh, J. H., Kim, D. J., Ko, K. S., Rhee, B. D., & Kim, D. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.10.016 · Cited by 48
Ziemssen, F., Lemmen, K. D., Bertram, B., Hammes, H., & Agostini, H. T. (2016) · Der Ophthalmologe · doi:10.1007/s00347-016-0315-8 · Cited by 50
Mo, B., Zhou, H.-Y., Jiao, X., & Zhang, F. (2017) · International Journal of Ophthalmology · doi:10.18240/ijo.2017.04.17 · Cited by 48
New-onset diabetes after pancreatoduodenectomy: A systematic review and meta-analysis
Scholten, L., Mungroop, T. H., Haijtink, S. A. L., Issa, Y., van Rijssen, L. B., Koerkamp, B. G., van Eijck, C. H. J., Busch, O. R., DeVries, J. H., & Besselink, M. G. (2018) · Surgery · doi:10.1016/j.surg.2018.01.024 · Cited by 53
Huang, C., Lu, H., Xu, J.-Y., Yu, H., Wang, X., & Zhang, X. (2018) · Biological Research · doi:10.1186/s40659-018-0169-4 · Cited by 49
Self-citationSingle herbal medicine for diabetic retinopathy
Zhang, H. W., Zhang, H., Grant, S., Wan, X., & Li, G. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007939.pub2 · Cited by 49
Diabetic Retinopathy, lncRNAs, and Inflammation: A Dynamic, Interconnected Network
Biswas, S., Sarabusky, M. A., & Chakrabarti, S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8071033 · Cited by 51
Role of Oral Antioxidant Supplementation in the Current Management of Diabetic Retinopathy
Alfonso-Muñoz, E. A., Matas, R. B.-S. D. L., Mataix, J., Martín, J. C. M., & Desco, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084020 · Cited by 53
“Diabetic retinopathy must be considered as multifactorial, as its development is a direct consequence of prolonged levels of hyperglycaemia, although it is influenced by the previously mentioned risk factors [1,11,13,14].”
BackgroundInfluentialNext generation telemedicine platforms to screen and triage
Ting, D. S. W., Gunasekeran, D. V., Wickham, L., & Wong, T. Y. (2019) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2019-315066 · Cited by 52
Self-citationde Ritter, R., Sep, S. J. S., Kallen, C., van Greevenbroek, M. M. J., de Jong, M., Vos, R. C., Bots, M. L., Reulen, J. P. H., Houben, A. J. H. M., Webers, C. A. B., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01290-x · Cited by 50
“In a large pooled analysis, the prevalence of diabetic retinopathy was similar in men and women [38].”
BackgroundReverse engineering the Ozurdex dexamethasone intravitreal implant
Costello, M. A., Liu, J. N., Wang, Y., Qin, B., Xu, X., Li, Q., Lynd, N. A., & Zhang, F. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122625 · Cited by 50
The evolving therapeutic landscape of diabetic retinopathy
Shughoury, A., Bhatwadekar, A. D., Jusufbegovic, D., Hajrasouliha, A. R., & Ciulla, T. A. (2023) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2023.2247987 · Cited by 49
“Therefore, the progressive and ultimately blinding nature of uncontrolled DR places it among the leading causes of blindness worldwide [2].”
BackgroundInfluentialFerroptosis Contributes to Microvascular Dysfunction in Diabetic Retinopathy
Liu, Q., Liu, C., Yi, W.-Z., Ouyang, P.-W., Yang, B.-F., Liu, Q., Liu, J., Wu, Y.-N., Liang, A.-R., Cui, Y., et al. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.01.019 · Cited by 50
Current Concepts in Diabetic Retinopathy
Song, S. J., & Wong, T. Y. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.6.416 · Cited by 54
Self-citationKaizu, Y., Nakao, S., Yoshida, S., Hayami, T., Arima, M., Yamaguchi, M., Wada, I., Hisatomi, T., Ikeda, Y., Ishibashi, T., et al. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-22306 · Cited by 47
“Diabetic retinopathy (DR) is a major cause of blindness among adults of working age worldwide.(1) The pathogenesis of DR is due to high glucose-related retinal microvascular complications such as microthrombosis.”
BackgroundMoon, B. G., Um, T., Lee, J., & Yoon, Y. H. (2017) · Ophthalmology Retina · doi:10.1016/j.oret.2017.07.003 · Cited by 47
Chan, J. C., Chee, M. L., Tan, N. Y. Q., Cheng, C., Wong, T. Y., & Sabanayagam, C. (2018) · Nutrition and Diabetes · doi:10.1038/s41387-018-0018-0 · Cited by 52
Self-citationChakravarthy, H., & Devanathan, V. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1188-x · Cited by 51
Jin, G., Xiao, W., Ding, X., Xu, X., An, L., Congdon, N. G., Zhao, J., & He, M. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-24280 · Cited by 48
“Second, race, which is considered an independent risk factor for DR, is another possible reason.(21,49) Many studies have investigated the relationship between ethnicity and DR, with typical associations to be dependent on differences in the control of established risk factors.”
BackgroundResultInfluentialAli, S. A., Zaitone, S. A., Dessouki, A. A., & Ali, A. A. (2019) · Experimental Eye Research · doi:10.1016/j.exer.2019.04.014 · Cited by 47
Graue-Hernández, E. O., la Parra, D. R.-D., Hernández-Jiménez, S. C., Aguilar-Salinas, C. A., Kershenobich, D., & Jiménez-Corona, A. (2020) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2019-000304 · Cited by 60
Insights into the growing popularity of artificial intelligence in ophthalmology
Rajalakshmi, R., Dutt, S., Sivaraman, A., & Savoy, F. M. (2020) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_1754_19 · Cited by 52
“[11] In India, one out of five people with diabetes has some form of retinopathy.”
BackgroundTang, Z., Chan, M. Y., Leung, W. Y., Wong, H. Y., Ng, C. M., Chan, V. T. T., Wong, R. L. M., Lok, J. K. H., Szeto, S., Chan, J. C. K., et al. (2020) · Eye · doi:10.1038/s41433-020-1020-z · Cited by 49
Self-citationSerum Iron and Risk of Diabetic Retinopathy
Chen, Y.-J., Chen, J., Tai, M., Liang, C., Chen, Y., & Chen, W. (2020) · Nutrients · doi:10.3390/nu12082297 · Cited by 48
“Poor control of diabetes and hypertension and long DM duration are strongly associated with DR [8].”
BackgroundMadrakhimov, S. B., Yang, J. Y., Kim, J. H., Han, J. W., & Park, T. K. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-020-00698-4 · Cited by 44
Visualizing the Knowledge Domain in Health Education: A Scientometric Analysis Based on CiteSpace
Chen, B., Shin, S., Wu, M., & Liu, Z. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19116440 · Cited by 52
Life style intervention improves retinopathy status-the Finnish Diabetes Prevention Study
Aro, A., Kauppinen, A., Kivinen, N., Selander, T., Kinnunen, K., Tuomilehto, J., Keinänen-Kiukaanniemi, S., Lindström, J., Uusitupa, M., & Kaarniranta, K. (2019) · Nutrients · doi:10.3390/nu11071691 · Cited by 46
“Globally, DR was the leading cause of blindness among the working-aged population [3,6,7].”
BackgroundInfluentialMimura, T., & Noma, H. (2025) · Antioxidants · doi:10.3390/antiox14101204 · Cited by 53
“Among the various forms of DR, proliferative DR (PDR) and diabetic macular edema (DME) are the major causes of significant visual impairment, imposing substantial socioeconomic burdens [3].”
Lim, L. S., Ling, L. H., Ong, P. G., Foulds, W. S., Tai, E. S., Wong, E. Y., Lee, S. Y., Wong, D., Cheung, C. M. G., & Wong, T. Y. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14301 · Cited by 47
Self-citationOgunyemi, O. I., & Kermah, D. (2015) · PubMed · Cited by 46
Cui, Y., Zhang, L., Zhang, M., Yang, X., Zhang, L., Kuang, J., Zhang, G., Liu, Q., Guo, H., & Meng, Q. (2017) · Scientific Reports · doi:10.1038/s41598-017-11365-z · Cited by 47
Kreft, D., McGuinness, M. B., Doblhammer, G., & Finger, R. P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195426 · Cited by 46
Refractive Changes Associated with Diabetes Mellitus
Kaštelan, S., Gverović-Antunica, A., Pelčić, G., Gotovac, M., Marković, I., & Kasun, B. (2018) · Seminars in Ophthalmology · doi:10.1080/08820538.2018.1519582 · Cited by 46
“Hyperglycemia is the most characteristic feature of diabetes and is considered to be one of the main risk factors for diabetic complications.(1,2) Glycosylated hemoglobin (HbA1c) is the most reliable lab-based blood test for glycemic control and gives information pertaining to blood glucose concentrations in the previ…”
BackgroundLiu, L., Gao, J., Bao, W.-L., Hu, C., Xu, Y., Zhao, B.-Y., Zheng, J., Fan, L., & Sun, Y. (2018) · Journal of Ophthalmology · doi:10.1155/2018/3926745 · Cited by 46
“Diabetic retinopathy (DR) is a major microvascular complication of diabetes and is a leading cause of acquired blindness in the population of working age worldwide [1, 2].”
BackgroundHsiao, C., Yang, C., Yang, C., Ho, T., Lai, T., & Hsieh, Y. (2019) · Eye · doi:10.1038/s41433-019-0549-1 · Cited by 46
Retinal and Choroidal Vascular Diseases: Past, Present, and Future: The 2021 Proctor Lecture
Campochiaro, P. A. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.14.26 · Cited by 46
Zhang, X., Zhao, S., Huang, Y., Ma, M., Li, B., Li, C., Zhu, X., Xu, X., Chen, H., Zhang, Y. Z., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.032626 · Cited by 47
“58 Prevalence of any DR was only 18% in patients with T2D with a diabetes duration <10 years, and about 86% in patients with T1D with a diabetes duration >20 years, 56 which means many patients with T1D have already developed DR and have been excluded from the current study.”
BackgroundSelf-citationLu, J., Hou, X., Zhang, L., Jiang, F., Hu, C., Bao, Y., & Jia, W. (2015) · Acta Diabetologica · doi:10.1007/s00592-014-0711-y · Cited by 48
“20–74 years [11] and severely influenced the quality of life in diabetic patients [12].”
BackgroundHe, J., Wang, H., Liu, Y., Li, W., Kim, D. J., & Hu, H. (2015) · Journal of Ophthalmology · doi:10.1155/2015/605946 · Cited by 49
“DR is one of the most common complications of DM and affects about 93 million people worldwide [2].”
On behalf of The Brazilian Type 1 Diabetes Study Group, Malerbi, F. K., Morales, P. H., Farah, M. E., Drummond, K. R. G., Mattos, T. C. L., Pinheiro, A. A., Mallmann, F., Perez, R. V., Leal, F. S. L., et al. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0110-8 · Cited by 45
“It is the main cause of preventable blindness in the economically active population in developed countries [2].”
BackgroundKhuu, L., Tayyari, F., Sivak, J. M., Flanagan, J. G., Singer, S., Brent, M. H., Huang, D., Tan, O., & Hudson, C. (2016) · Acta Ophthalmologica · doi:10.1111/aos.13230 · Cited by 45
“Following 20 years of diabetes, nearly all patients with type 1 and type 2 diabetes mellitus will sufferfromsomeformofretinopathy (Klein & Klein 2010; Yau et al. 2012).”
BackgroundInfluentialRNCR3: A regulator of diabetes mellitus-related retinal microvascular dysfunction
Shan, K. Y., Li, C., Liu, C., Liu, X., & Yan, B. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.11.110 · Cited by 45
D'Amico, A. G., Maugeri, G., Rasà, D. M., La Cognata, V., Saccone, S., Federico, C., Cavallaro, S., & D'Agata, V. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25971 · Cited by 44
“Clinical signs include thickening of retinal layers, macula edema, exudate deposition, and blood retinal barrier (BRB) breakdown (Bhagat, Grigorian, Tutela, & Zarbin, 2009; Ding & Wong, 2012; Lightman & Towler, 2003; Moss, Klein, & Klein, 1998; Yau et al., 2012; Zhang, Bao, Lai, Rapkins, & Gillies, 2008).”
Retinopathy with central oedema in an INS C94Y transgenic pig model of long-term diabetes
Kleinwort, K. J. H., Amann, B., Hauck, S. M., Hirmer, S., Blutke, A., Renner, S., Uhl, P., Lutterberg, K., Sekundo, W., Wolf, E., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4290-7 · Cited by 48
“This is the most common microvascular end-stage complication, with a 16-year incidence of 31% in type 1 diabetes [26] and 15% in type 2 diabetes (over 20 years) [27].”
BackgroundLewis, A. D., Hogg, R. E., Chandran, M., Musonda, L., North, L., Chakravarthy, U., Sivaprasad, S., & Menon, G. (2018) · Eye · doi:10.1038/s41433-018-0055-x · Cited by 50
“On the other hand, for PDR our data are similar to previously reported prevalence in other studies of sub-Saharan populations [19, 20] and worldwide data [12, 14].”
BackgroundResultThapa, R., Twyana, S. N., Paudyal, G., Khanal, S. P., van Nispen, R. M. A., Tan, H. S., Thapa, S. S., & van Rens, G. H. M. B. (2018) · Clinical ophthalmology · doi:10.2147/opth.s157560 · Cited by 54
“This finding is consistent with reports of lower prevalence of DR within the developing world.(4) The differences in DR prevalence may be due to a longer life expectancy in the developed world.”
ResultParikh, R., Pirakitikulr, N., Chhablani, J. K., Sakurada, Y., Singh, R. P., & Modi, Y. S. (2018) · Ophthalmology Retina · doi:10.1016/j.oret.2018.08.002 · Cited by 47
Zhang, Z., Qin, X., & Zhang, J. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00444.2018 · Cited by 49
Sugiyama, T., Imai, K., Ihana‐Sugiyama, N., Tanaka, H., Yanagisawa‐Sugita, A., Sasako, T., Higashi, T., Okamura, T., Yamauchi, T., Ueki, K., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.05.029 · Cited by 46
Zhu, Y., Cui, Y., Wang, J. C., Lu, Y., Zeng, R., Katz, R., Wu, D. M., Eliott, D., Vavvas, D. G., Husain, D., et al. (2020) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2020.03.004 · Cited by 47
Self-citation
Metadata
- Authors
- Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., Haffner, S., Hamman, R. F., Ikram, M. K., Kayama, T., Klein, B. E. K., Klein, R., Krishnaiah, S., Mayurasakorn, K., O’Hare, J. P., Orchard, T. J., Porta, M., Rema, M., Roy, M. S., Sharma, T., Shaw, J., Taylor, H., Tielsch, J. M., Varma, R., Wang, J. J., Wang, N., West, S., Xu, L., Yasuda, M., Zhang, X., Mitchell, P., Wong, T. Y., & for the Meta-Analysis for Eye Disease (META-EYE) Study Group
- Affiliations
- The University of Melbourne (AU)
- Allergan (United States) (US)
- Aarhus University Hospital (DK)
- Taipei Veterans General Hospital (TW)
- Amsterdam Public Health (NL)
- London School of Hygiene & Tropical Medicine (GB)
- Odense University Hospital (DK)
- Shavano Park, Texas
- Colorado School of Public Health (US)
- Erasmus MC (NL)
- Yamagata University (JP)
- University of Wisconsin–Madison (US)
- L V Prasad Eye Institute (IN)
- Samut Sakhon Hospital (TH)
- University of Warwick (GB)
- University of Pittsburgh (US)
- University of Turin (IT)
- Madras Diabetes Research Foundation (IN)
- Rutgers New Jersey Medical School (US)
- Sankara Nethralaya (IN)
- Baker Heart and Diabetes Institute (AU)
- Johns Hopkins University (US)
- University of Southern California (US)
- The University of Sydney (AU)
- Beijing Tongren Hospital (CN)
- Johns Hopkins Hospital (US)
- Kyushu University (JP)
- Centers for Disease Control and Prevention (US)
- Corresponding author
- Wong, Tien Y.
- ORCID
- Rogers, Sophie L.
- Kawasaki, Ryo
- Lamoureux, Ecosse L.
- Bek, Toke
- Chen, Shih-Jen
- Fletcher, Astrid
- Grauslund, Jakob
- Hamman, Richard F.
- Ikram, M. Kamran
- Klein, Barbara E.K.
- Klein, Ronald
- Krishnaiah, Sannapaneni
- Mayurasakorn, Korapat
- Orchard, Trevor J.
- Porta, Massimo
- Sharma, Tarun
- Shaw, Jonathan
- Taylor, Hugh
- Tielsch, James M.
- Varma, Rohit
- Wang, Jie Jin
- West, Sheila
- Xu, Liang
- Zhang, Xinzhi
- Mitchell, Paul
- Wong, Tien Y.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-02-10
- Volume
- 35
- Issue
- 3
- Pages
- 556-564
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3322721
- OpenAlex
- W2138480916
- Cited by
- 4,985
- References
- 38
- Citations by year
- 2026: 374 · 2025: 447 · 2024: 477 · 2023: 429 · 2022: 499 · 2021: 544 · 2020: 520 · 2019: 365 · 2018: 331 · 2017: 305 · 2016: 238 · 2015: 198 · 2014: 139 · 2013: 80 · 2012: 30
- FWCI
- 21.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by-nc-nd)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- National University of Singapore (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Research to Prevent Blindness
- Hyderabad Eye Research Foundation
- Oogfonds
- Algemene Nederlandse Vereniging ter voorkoming van Blindheid
- National Institutes of Health
- Allergan
- Medical Research Council
- National Eye Institute (EY0-6594, R01 EY 09860, R01EY009860, U10EY006594, R01EY016379)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetic retinopathy, vision-threatening diabetic retinopathy, proliferative diabetic retinopathy, diabetic macular edema, global prevalence, risk factors, diabetes duration, glycemic control, HbA1c, blood pressure, type 1 diabetes, type 2 diabetes, fundus images, public health burden
- MeSH terms
- Adult, Aged, Blood Glucose, Blood Pressure, Diabetic Retinopathy, Female, Humans, Male, Middle Aged, Risk Factors, Prevalence, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.